Citations 329

Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy

Neurology | May 2, 2013 | Volume: 80 | Issue: 22 | Pages: 2076-2078

10.1212/wnl.0b013e318294b2eb | PMID 23635960

Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis

Neurology | April 18, 2013 | Volume: 80 | Issue: 19 | Pages: 1771-1777

10.1212/wnl.0b013e3182919059 | PMID 23596077

CSF1R mutations link POLD and HDLS as a single disease entity

Neurology | February 14, 2013 | Volume: 80 | Issue: 11 | Pages: 1033-1040

10.1212/wnl.0b013e31828726a7 | PMID 23408870

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

Journal of Medical Genetics | November 2, 2012 | Volume: 49 | Issue: 11 | Pages: 721-726

10.1136/jmedgenet-2012-101155 | PMID 23125461

Background Two recent studies identified a mutation (p.Asp620Asn) in the vacuolar protein sorting 35 gene as a cause for an autosomal dominant form of Parkinson disease . Although additional missense variants were described, their pathogenic role yet remains inconclusive. Methods and results We performed the largest multi-center study to ascertain the frequency and pathogenicity of the reported vacuolar protein sorting 35 gene variants in more than 15,000 individuals worldwide. p.Asp620Asn was detected in 5 familial and 2 sporadic PD cases and not in healthy controls, p.Leu774Met in 6 cases and 1 control, p.Gly51Ser in 3 cases and 2 controls. Overall analyses did not reveal any significant increased risk for p.Leu774Met and p.Gly51Ser in our cohort. Conclusions Our study apart from identifying the p.Asp620Asn variant in familial cases also identified it in idiopathic Parkinson disease cases, and thus provides genetic evidence for a role of p.Asp620Asn in Parkinson disease in different populations worldwide.
Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke

European Journal of Neurology | August 7, 2012 | Volume: 20 | Issue: 2 | Pages: 300-308

10.1111/j.1468-1331.2012.03846.x | PMID 22882272

BackgroundIschaemic stroke shares common traditional risk factors with coronary artery disease (CAD) and myocardial infarction (MI). This study evaluated whether genetic risk factors for CAD and MI also affect susceptibility to ischaemic stroke in Caucasians and African Americans.MethodsIncluded in the study were a Caucasian series (713 ischaemic stroke patients, 708 controls) and a small African American series (166 ischaemic stroke patients, 117 controls). Twenty single‐nucleotide polymorphisms (SNPs) previously shown to be associated with CAD or MI were genotyped and assessed for association with ischaemic stroke and ischaemic stroke subtypes using odds ratios (ORs) from multivariable logistic regression models.ResultsIn Caucasians, four SNPs on chromosome 9p21 were significantly associated with risk of cardioembolic stroke, the strongest of which was rs1333040 (OR 1.55, P = 0.0007); similar but weaker trends were observed for small vessel stroke, with no associations observed regarding large vessel stroke. Chromosome 9p21 SNPs were also associated with risk of ischaemic stroke in African Americans (rs1333040, OR 0.65, P = 0.023; rs1333042, OR 0.55, P = 0.070; rs2383207, OR 0.55, P = 0.070). The PSMA6 SNP rs1048990 on chromosome 14q13 was associated with overall ischaemic stroke in both Caucasians (OR 0.80, P = 0.036) and African Americans (OR 0.31, P = 0.020).ConclusionsOur results provide evidence that chromosome 9p21 variants are associated with cardioembolic ischaemic stroke in Caucasians and with overall ischaemic stroke in African Americans. The PSMA6 variant rs1048990 also appears to affect susceptibility to ischaemic stroke in both populations. These findings require validation, particularly the preliminary findings regarding African Americans given the small size of that series.
MRI characteristics and scoring in HDLS due to CSF1R gene mutations

Neurology | July 27, 2012 | Volume: 79 | Issue: 6 | Pages: 566-574

10.1212/wnl.0b013e318263575a | PMID 22843259

C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository

Neurology | July 20, 2012 | Volume: 79 | Issue: 5 | Pages: 482-483

10.1212/wnl.0b013e31826170f1 | PMID 22815561

P1‐178: Anteromedial temporal lobe DTI and structural MRI changes in presymptomatic and symptomatic MAPT mutation carriers

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2012.05.456

IC‐P‐134: Anteromedial temporal lobe diffusion tensor imaging and structural MRI changes in presymptomatic and symptomatic microtubule‐associated protein tau (MAPT) mutation carriers

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2012.05.168

Large-scale replication and heterogeneity in Parkinson disease genetic loci

Neurology | July 12, 2012 | Volume: 79 | Issue: 7 | Pages: 659-667

10.1212/wnl.0b013e318264e353 | PMID 22786590